| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 151,669 | 156,807 | 149,952 | 173,632 |
| Cost of goods and services sold-Service | 80,402 | 82,383 | - | - |
| Cost of goods and services sold-Product | 21,374 | 25,022 | - | - |
| Cost of goods and services sold | - | - | 107,332 | 133,503 |
| Us-gaap_disposalgroupnotdiscontinuedoperationgainlossondisposal | - | - | - | 121,493 |
| Selling, general and administrative | 53,804 | 59,597 | 59,086 | 98,203 |
| Research and development | 30,078 | 30,342 | 30,841 | 28,770 |
| Amortization of intangible assets | 19,531 | 19,444 | 19,861 | 20,433 |
| Gain on sale of assets | 101,576 | - | - | - |
| Us-gaap_operatingexpenses | - | - | - | 159,416 |
| Total costs and expenses | 103,613 | 216,788 | 217,120 | - |
| Operating income (loss) | 48,056 | -59,981 | -67,168 | 14,216 |
| Interest income | 3,023 | 3,287 | 4,681 | 2,928 |
| Interest expense | 11,358 | 70,327 | 15,466 | 17,359 |
| Fair value changes of derivative instruments, net | -38 | 16 | -273 | -1 |
| Other Nonoperating Income Expense | 1,748 | -35,515 | 4,852 | 48,636 |
| Other income (expense), net | -6,625 | -102,539 | -6,206 | 34,204 |
| Income (loss) before income taxes and investment losses | 41,431 | -162,520 | -73,374 | 48,420 |
| Income tax (provision) benefit | 19,797 | -14,079 | -5,770 | 23,527 |
| Net income (loss) before investment losses | 21,634 | -148,441 | -67,604 | 24,893 |
| Loss from investments in investees | -3 | 0 | -9 | -3 |
| Net loss | 21,631 | -148,441 | -67,613 | 24,890 |
| Loss per share, basic | 0.03 | -0.19 | -0.1 | 0.04 |
| Loss per share, diluted | 0.03 | -0.19 | - | 0.03 |
| Weighted average common shares outstanding, basic | 777,154,808 | 788,006,992 | 671,577,429 | 694,622,466 |
| Weighted average common shares outstanding, diluted | 779,919,259 | 788,006,992 | - | 998,363,636 |
OPKO HEALTH, INC. (OPK)
OPKO HEALTH, INC. (OPK)